Oraya Therapeutics announced that initial three-year safety follow-up data from its INTREPID study of Oraya Therapy stereotactic radiotherapy for the treatment of wet age-related macular degeneration (AMD) were presented for the first time ...
Tags: Oraya Therapeutics, Medicine
Bayer has received approval from Health Canada for Eylea (aflibercept, solution for intravitreal injection) for treatment of patients with neovascular (wet) age-related macular degeneration (wet AMD). AMD, a progressive eye disease that ...
Tags: Wet AMD Patients, Bayer
Lpath has won a US patent covering methods of using monoclonal antibodies for the treatment and prevention of ocular conditions, including wet age-related macular degeneration (AMD). The patent includes the use of monoclonal antibodies, ...
The European Commission (EC) has approved Bayer HealthCare's EYLEA (aflibercept solution for injection) at a recommended dose of 2 mg for the treatment of wet age-related macular degeneration (wet AMD). Formulated as an iso-osmotic ...
Tags: European Commission, Bayer, Aflibercept Solution, EYLEA
Regeneron Pharmaceuticals has received Japanese Ministry of Health,Labour and Welfare(MHLW)approval for its Eylea(aflibercept)injection to treat patients with neovascular age-related macular degeneration(wet AMD)symptoms. Regeneron chief ...
Tags: Regeneron Pharmaceuticals, Eylea Injection, wet AMD, George Yancopoulos